Doximity, Inc. (DOCS)

USD 51.03

(-4.1%)

Revenue Summary of Doximity, Inc.

Doximity, Inc.'s latest annual revenue in 2024 was 475.42 Million USD , up 13.45% from previous year.
Doximity, Inc.'s latest quarterly revenue in 2024 FY was 475.42 Million USD , up 13.45% from previous quarter.
Doximity, Inc. reported a annual revenue of 419.05 Million USD in annual revenue 2023, up 21.98% from previous year.
Doximity, Inc. reported a annual revenue of 343.54 Million USD in annual revenue 2022, up 66.05% from previous year.
Doximity, Inc. reported a quarterly revenue of 118.05 Million USD for 2024 Q4, down -12.73% from previous quarter.
Doximity, Inc. reported a quarterly revenue of 113.61 Million USD for 2024 Q2, up 4.74% from previous quarter.

Annual Revenue Chart of Doximity, Inc. (2024 - 2019)

Historical Annual Revenue of Doximity, Inc. (2024 - 2019)

Year	Revenue	Revenue Growth
2024	475.42 Million USD	13.45%
2023	419.05 Million USD	21.98%
2022	343.54 Million USD	66.05%
2021	206.89 Million USD	77.76%
2020	116.38 Million USD	35.82%
2019	85.69 Million USD	0.0%

Year	Revenue	Revenue Growth
2024 FY	475.42 Million USD	13.45%
2024 Q4	118.05 Million USD	-12.73%
2024 Q2	113.61 Million USD	4.74%
2024 Q3	135.28 Million USD	19.08%
2024 Q1	108.46 Million USD	-2.25%
2023 Q3	115.26 Million USD	12.8%
2023 FY	419.05 Million USD	21.98%
2023 Q4	110.96 Million USD	-3.73%
2023 Q2	102.18 Million USD	12.74%
2023 Q1	90.63 Million USD	-3.22%
2022 Q3	97.87 Million USD	23.35%
2022 Q4	93.65 Million USD	-4.31%
2022 Q1	72.66 Million USD	8.97%
2022 FY	343.54 Million USD	66.05%
2022 Q2	79.35 Million USD	9.19%
2021 Q4	66.68 Million USD	13.59%
2021 FY	206.89 Million USD	77.76%
2021 Q1	36.38 Million USD	0.09%
2021 Q3	58.7 Million USD	30.14%
2021 Q2	45.11 Million USD	23.98%
2020 Q3	32.42 Million USD	0.0%
2020 Q4	36.35 Million USD	12.11%
2020 FY	116.38 Million USD	35.82%
2019 FY	85.69 Million USD	0.0%

Peer Revenue Comparison of Doximity, Inc.

Name	Revenue	Revenue Difference
American Well Corporation	259.04 Million USD	-83.527%
Evolent Health, Inc.	1.96 Billion USD	75.792%
MultiPlan Corporation	961.52 Million USD	50.555%
Phreesia, Inc.	356.29 Million USD	-33.433%
Teladoc Health, Inc.	2.6 Billion USD	81.732%
Veeva Systems Inc.	2.36 Billion USD	79.886%